---
title: "Methods"
css: pubs.css
---

\
\

::: {style="font-size: 95%;"}
{{< fa envelope size=xs >}} Corresponding author; † [Student/Supervisee]{.underline}\
{{< ai open-access size=lg >}} Open-access
:::

::: {style="font-size: 92%;"}

-   **Mao, L.** {{< fa envelope size=xs >}} (2025). [Win ratio for partially ordered data](http://doi.org/10.5705/ss.202023.0321){target="_blank"}. [*Statistica Sinica*](https://www3.stat.sinica.edu.tw/statistica/){target="_blank"}, 10.5705/ss.202023.0321. {{< ai open-access size=lg >}} \[R-package [`poset`](https://lmaowisc.github.io/poset){target="_blank"}\]
-   **Mao, L.** {{< fa envelope size=xs >}} (2025). [Regularized win ratio regression for variable selection and risk prediction, with an application to a cardiovascular trial](https://doi.org/10.1186/s12874-025-02554-w).  [*BMC Medical Research Methodology*](https://bmcmedresmethodol.biomedcentral.com/), 25, 102. {{< ai open-access size=lg >}} \[Website [WRNet](https://lmaowisc.github.io/wrnet/); [Presentation](https://lmaowisc.github.io/wrnet/presentation.html)\]
-   **Mao, L.** {{< fa envelope size=xs >}} (2024). [Robust improvement of efficiency using information on covariate distribution](https://doi.org/10.1214/24-EJS2311){target="_blank"}. [*Electronic Journal of Statistics*](https://projecteuclid.org/euclid.ejs){target="_blank"}, 18, 4640-4666. {{< ai open-access size=lg >}}
-   **Mao, L.** {{< fa envelope size=xs >}} (2024). [Defining estimand for the win ratio: separate the true effect from censoring](http://doi.org/10.1177/17407745241259356){target="_blank"}. [*Clinical Trials*](https://journals.sagepub.com/home/ctj){target="_blank"}, 21, 584-594. {{< ai open-access size=lg >}} \[[Presentation](https://lmaowisc.github.io/BMI741/win_ratio_estimand.html){target="_blank"}\]
-   Cui, Y., Huang, B., **Mao, L.**, Uno, H., Wei, L.-J., and Tian, L. (2024). [Inferences for the distribution of the duration of response in a comparative clinical study](https://doi.org/10.1177/17407745241264188){target="_blank"}. [*Clinical Trials*](https://journals.sagepub.com/home/ctj){target="_blank"}, 21, 541-552.
-   **Mao, L.** {{< fa envelope size=xs >}} (2024). [Wilcoxon–Mann–Whitney statistics in randomized trials with non-compliance](https://doi.org/10.1214/23-EJS2209){target="_blank"}. [*Electronic Journal of Statistics*](https://projecteuclid.org/journals/electronic-journal-of-statistics){target="_blank"}, 18, 465-489. {{< ai open-access size=lg >}} \[An earlier version of this manuscript won the 2019 IMS New Researcher Travel Award\]
-   **Mao, L.** {{< fa envelope size=xs >}} and [Wang, T.]{.underline}† (2024). [Dissecting the restricted mean time in favor of treatment](https://doi.org/10.1080/10543406.2023.2210658){target="_blank"}. [*Journal of Biopharmaceutical Statistics*](https://www.tandfonline.com/toc/lbps20/current){target="_blank"}, 34, 111-126. {{< ai open-access size=lg >}}
-   [Wang, T.]{.underline}†, **Mao, L.**, Cocco, A., and Kim, K. (2024). [Statistical inference for time-to-event data in non-randomized cohorts with selective attrition](https://doi.org/10.1002/sim.9952){target="_blank"}. [*Statistics in Medicine*](https://onlinelibrary.wiley.com/journal/10970258){target="_blank"}, 43, 216-232. {{< ai open-access size=lg >}}
-   **Mao, L.** {{< fa envelope size=xs >}} (2023). [Study design for restricted mean time analysis of recurrent events and death](https://doi.org/10.1111/biom.13923){target="_blank"}. [*Biometrics*](https://academic.oup.com/biometrics){target="_blank"}, 79, 3701-3714. {{< ai open-access size=lg >}} \[R-package [`rmt`](https://lmaowisc.github.io/rmt){target="_blank"}\]
-   **Mao, L.** {{< fa envelope size=xs >}} (2023). [Nonparametric inference of general while-alive estimands for recurrent events](https://doi.org/10.1111/biom.13709){target="_blank"}. [*Biometrics*](https://academic.oup.com/biometrics){target="_blank"}, 79, 1749-1760. {{< ai open-access size=lg >}} \[[Presentation](https://lmaowisc.github.io/BMI741/wa.html){target="_blank"}; R-package [`WA`](https://lmaowisc.github.io/WA){target="_blank"}\]
-   **Mao, L.** {{< fa envelope size=xs >}} (2023). [Power and sample size calculations for the restricted mean time analysis of prioritized composite endpoints](https://doi.org/10.1080/19466315.2022.2110936){target="_blank"}. [*Statistics in Biopharmaceutical Research*](https://www.tandfonline.com/journals/usbr20){target="_blank"}, 15, 540-548. {{< ai open-access size=lg >}} \[R-package [`rmt`](https://lmaowisc.github.io/rmt){target="_blank"}\]
-   **Mao, L.** {{< fa envelope size=xs >}} (2023). [On restricted mean time in favor of treatment](https://doi.org/10.1111/biom.13570){target="_blank"}. [*Biometrics*](https://academic.oup.com/biometrics){target="_blank"}, 79, 61-72. {{< ai open-access size=lg >}} \[[Presentation](https://lmaowisc.github.io/BMI741/rmt.html){target="_blank"}; [R-package `rmt`](https://lmaowisc.github.io/rmt){target="_blank"}\]
-   **Mao, L.** {{< fa envelope size=xs >}} (2022). [Nonparametric inference of complier quantile treatment effects in randomized trials with imperfect compliance](https://doi.org/10.1080/24709360.2021.2024972){target="_blank"}. [*Biostatistics & Epidemiology*](https://www.tandfonline.com/journals/tbep20){target="_blank"}, 6, 249-265.
-   He, Y., Kim S., **Mao, L.**, and Ahn, K.W. (2022). [Marginal semiparametric transformation models for clustered multivariate competing risks data](https://doi.org/10.1002/sim.9573){target="_blank"}. [*Statistics in Medicine*](https://onlinelibrary.wiley.com/journal/10970258){target="\"_blank"}, 41, 5349-5364.
-   [Wang, T.]{.underline}† and **Mao, L.** {{< fa envelope size=xs >}} (2022). [Stratified proportional win-fractions regression analysis](https://doi.org/10.1002/SIM.9570){target="_blank"}. [*Statistics in Medicine*](https://onlinelibrary.wiley.com/journal/10970258){target="\"_blank"}, 41, 5305-5318. {{< ai open-access size=lg >}} \[R-package [`WR`](https://lmaowisc.github.io/WR/){target="\"_blank"}\]
-   **Mao, L.** {{< fa envelope size=xs >}}, Kim, K., and [Miao, X.]{.underline}† (2022). [Sample size formula for general win ratio analysis](https://doi.org/10.1111/biom.13501){target="_blank"}. [*Biometrics*](https://academic.oup.com/biometrics){target="\"_blank"}, 78, 1257-1268. {{< ai open-access size=lg >}} \[R-package [`WR`](https://lmaowisc.github.io/WR/){target="\"_blank"}\]
-   **Mao, L.** {{< fa envelope size=xs >}} (2022). [Identification of the outcome distribution and sensitivity analysis under weak confounder-instrument interaction](https://doi.org/10.1016/j.spl.2022.109590){target="_blank"}. [*Statistics & Probability Letters*](https://www.journals.elsevier.com/statistics-and-probability-letters){target="\"_blank"}, 189, 109590. {{< ai open-access size=lg >}}
-   **Mao, L.** {{< fa envelope size=xs >}} (2022). [On the relative efficiency of intent-to-treat Wilcoxon–Mann–Whitney test in the presence of non-compliance](https://doi.org/10.1093/biomet/asab053){target="_blank"}. [*Biometrika*](https://academic.oup.com/biomet){target="\"_blank"}, 109, 873-880. {{< ai open-access size=lg >}}
-   **Mao, L.** {{< fa envelope size=xs >}}, Kim, K., and [Li, Y.]{.underline}† (2022). [On recurrent-event win ratio](https://doi.org/10.1177/09622802221084134){target="_blank"}. [*Statistical Methods in Medical Research*](https://journals.sagepub.com/home/smm){target="\"_blank"}, 31, 1120-1134. \[[Presentation](https://biostat.wisc.edu/%7Elmao/research/slides/RWR_IISA_2021.pdf){target="_blank"}; R-package [`WR`](https://lmaowisc.github.io/WR/){target="\"_blank"}\]
-   **Mao, L.** {{< fa envelope size=xs >}} and [Wang, T.]{.underline}† (2021). [A class of proportional win-fractions regression models for composite outcomes](https://doi.org/10.1111/biom.13382){target="_blank"}. [*Biometrics*](https://academic.oup.com/biometrics){target="_blank"}, 77, 1265-1275. {{< ai open-access size=lg >}} \[[Presentation](https://biostat.wisc.edu/%7Elmao/research/slides/WR.pdf){target="\"_blank"}; R-package [`WR`](https://lmaowisc.github.io/WR/){target="\"_blank"}\]
-   **Mao, L.** {{< fa envelope size=xs >}} and Kim, K. (2021). [Statistical models for composite endpoints of death and non-fatal events: a review](https://doi.org/10.1080/19466315.2021.1927824){target="_blank"}. [*Statistics in Biopharmaceutical Research*](https://www.tandfonline.com/toc/usbr20/current){target="_blank"}, 13, 260-269.
-   [Li, Y.]{.underline}†, Liang, M., **Mao, L.** {{< fa envelope size=xs >}}, and Wang, S. (2021). [Robust estimation and variable selection for the accelerated failure time model](https://doi.org/10.1002/sim.9042){target="_blank"}. [*Statistics in Medicine*](https://onlinelibrary.wiley.com/journal/10970258){target="_blank"}, 40, 4473-4491.
-   **Mao, L.** {{< fa envelope size=xs >}} (2020). [A unified approach to the calculation of information operators in semiparametric models](https://doi.org/10.1093/biomet/asaa037){target="_blank"}. [*Biometrika*](https://academic.oup.com/biomet){target="\"_blank"}, 107, 983-995.
-   Dong, G., **Mao, L.**, Huang, B., Gamalo-Siebers, M., Wang, J., Yu, G., and Hoaglin, D. (2020). [The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring](https://doi.org/10.1080/10543406.2020.1757692){target="_blank"}. [*Journal of Biopharmaceutical Statistics*](https://www.tandfonline.com/journals/gbps20){target="\"_blank"}, 30, 882-899.
-   **Mao, L.** {{< fa envelope size=xs >}} (2019). [Proportional hazards regression of survival-sacrifice data with cause-of-death information in animal carcinogenicity studies](https://doi.org/10.1002/sim.8201){target="_blank"}. [*Statistics in Medicine*](https://onlinelibrary.wiley.com/journal/10970258){target="\"_blank"}, 38, 3628-3641.
-   **Mao, L.** {{< fa envelope size=xs >}} (2019). [Nonparametric inference on tumor incidence with partially identified cause-of-death data](http://doi.org/10.1007/978-3-030-15310-6_1){target="_blank"}. In: L. Zhang et al. (eds) [*Contemporary Biostatistics with Biopharmaceutical Applications*](https://www.springer.com/us/book/9783030153090#aboutBook){target="_blank"}, pp 3-18, [*Springer*](https://www.springer.com/gp){target="_blank"}. {{< ai open-access size=lg >}}
-   **Mao, L.** {{< fa envelope size=xs >}} (2019). [Nonparametric identification and estimation of current status data in the presence of death](https://doi.org/10.1111/stan.12175){target="_blank"}. [*Statistica Neerlandica*](https://onlinelibrary.wiley.com/journal/14679574){target="\"_blank"}, 73, 395-413.
-   **Mao, L.** {{< fa envelope size=xs >}} (2019). [On the alternative hypotheses for the win ratio](https://doi.org/10.1111/biom.12954){target="_blank"}. [*Biometrics*](https://academic.oup.com/biometrics){target="\"_blank"}, 75, 347-351.
-   **Mao, L.** {{< fa envelope size=xs >}} (2018). [On causal estimation using *U*-statistics](https://doi.org/10.1093/biomet/asx071){target="_blank"}. [*Biometrika*](https://academic.oup.com/biomet){target="\"_blank"}, 105, 215-220. \[[Presentation](https://biostat.wisc.edu/%7Elmao/research/slides/RSS_Ustat.pdf){target="\"_blank"}\]
-   **Mao, L.**, Lin, D.Y., and Zeng, D. (2017). [Semiparametric regression analysis of interval-censored competing risks data](https://doi.org/10.1111/biom.12664){target="_blank"}. [*Biometrics*](https://academic.oup.com/biometrics){target="\"_blank"}, 73, 857–865. \[An earlier version of this manuscript won the 2016 ASA Biometrics Section Travel Award and the 2016 ENAR RAB Poster Award\]
-   **Mao, L.** and Lin, D.Y. (2017). [Efficient estimation in semiparametric transformation models for the cumulative incidence of competing risks](https://doi.org/10.1111/rssb.12177){target="_blank"}. [*Journal of the Royal Statistical Society, Series B*](https://rss.onlinelibrary.wiley.com/journal/14679868){target="\"_blank"}, 79, 573–587. {{< ai open-access size=lg >}} \[An earlier version of this manuscript won the 2015 ENAR Distinguished Student Paper Award\]
-   Zeng, D., **Mao, L.**, and Lin, D.Y. (2016). [Maximum likelihood estimation for semiparametric transformation models with interval-censored data](https://doi.org/10.1093/biomet/asw013){target="_blank"}. [*Biometrika*](https://academic.oup.com/biomet){target="\"_blank"}, 103, 253-271.
-   **Mao, L.** and Lin, D.Y. (2016). [Semiparametric regression for the weighted composite endpoint of recurrent and terminal events](https://doi.org/10.1093/biostatistics/kxv050){target="_blank"}. [*Biostatistics*](https://academic.oup.com/biostatistics){target="\"_blank"}, 17, 390-403. \[An earlier version of this manuscript won the 2015 ASA Biopharmaceutical Section Student Paper Award\]
-   Gallo, P., **Mao, L.**, and Shih, V.H. (2014). [Alternative views on setting clinical trial futility criteria](https://doi.org/10.1080/10543406.2014.932285){target="_blank"}. [*Journal of Biopharmaceutical Statistics*](https://www.tandfonline.com/journals/lbps20){target="\"_blank"}, 24, 976-993.
:::
